Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Type 3

NCT00992771 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Spinocerebellar Ataxia Type 3

Interventions

DRUG: varenicline
DRUG: placebo

Sponsor

University of South Florida

Collaborators

[object Object]
[object Object]
[object Object]